메뉴 건너뛰기




Volumn 15, Issue 1, 2015, Pages

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma

Author keywords

Biliary tract cancer; Cholangiocarcinoma; FISH; Immunohistochemistry; ROS1

Indexed keywords

PROTEIN TYROSINE KINASE; ROS1 PROTEIN; UNCLASSIFIED DRUG; ONCOPROTEIN; ROS1 PROTEIN, HUMAN;

EID: 84944462899     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1737-4     Document Type: Article
Times cited : (21)

References (36)
  • 1
    • 0036892977 scopus 로고    scopus 로고
    • Changing international trends in mortality rates for liver, biliary and pancreatic tumours
    • Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37(6):806-13.
    • (2002) J Hepatol , vol.37 , Issue.6 , pp. 806-813
    • Khan, S.A.1    Taylor-Robinson, S.D.2    Toledano, M.B.3    Beck, A.4    Elliott, P.5    Thomas, H.C.6
  • 2
    • 84896723581 scopus 로고    scopus 로고
    • New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma
    • Patel T. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol. 2014;49(2):165-72.
    • (2014) J Gastroenterol , vol.49 , Issue.2 , pp. 165-172
    • Patel, T.1
  • 3
    • 56349107784 scopus 로고    scopus 로고
    • Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma
    • Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg. 2008;32(12):2675-80.
    • (2008) World J Surg , vol.32 , Issue.12 , pp. 2675-2680
    • Nakagohri, T.1    Kinoshita, T.2    Konishi, M.3    Takahashi, S.4    Gotohda, N.5
  • 5
    • 15944425099 scopus 로고    scopus 로고
    • Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins
    • Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery. 2005;137(4):396-402.
    • (2005) Surgery , vol.137 , Issue.4 , pp. 396-402
    • Sakamoto, Y.1    Kosuge, T.2    Shimada, K.3    Sano, T.4    Ojima, H.5    Yamamoto, J.6    Yamasaki, S.7    Takayama, T.8    Makuuchi, M.9
  • 6
    • 58049170380 scopus 로고    scopus 로고
    • The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer
    • Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta. 2009;1795(1):37-52.
    • (2009) Biochim Biophys Acta , vol.1795 , Issue.1 , pp. 37-52
    • Acquaviva, J.1    Wong, R.2    Charest, A.3
  • 16
    • 84881245421 scopus 로고    scopus 로고
    • Molecular pathways: ROS1 fusion proteins in cancer
    • Davies KD, Doebele RC. Molecular pathways: ROS1 fusion proteins in cancer. Clin Cancer Res. 2013;19(15):4040-5.
    • (2013) Clin Cancer Res , vol.19 , Issue.15 , pp. 4040-4045
    • Davies, K.D.1    Doebele, R.C.2
  • 18
    • 77954818058 scopus 로고    scopus 로고
    • The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
    • Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-4.
    • (2010) Ann Surg Oncol , vol.17 , Issue.6 , pp. 1471-1474
    • Edge, S.B.1    Compton, C.C.2
  • 19
    • 79960001615 scopus 로고    scopus 로고
    • Pathological classification of intrahepatic cholangiocarcinoma based on a new concept
    • Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2(12):419-27.
    • (2010) World J Hepatol , vol.2 , Issue.12 , pp. 419-427
    • Nakanuma, Y.1    Sato, Y.2    Harada, K.3    Sasaki, M.4    Xu, J.5    Ikeda, H.6
  • 20
    • 0242522356 scopus 로고    scopus 로고
    • Intrahepatic cholangiocarcinoma: macroscopic type and stage classification
    • Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10(4):288-91.
    • (2003) J Hepatobiliary Pancreat Surg , vol.10 , Issue.4 , pp. 288-291
    • Yamasaki, S.1
  • 22
    • 84888362036 scopus 로고    scopus 로고
    • Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
    • Saborowski A, Saborowski M, Davare MA, Druker BJ, Klimstra DS, Lowe SW. Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target. Proc Natl Acad Sci U S A. 2013;110(48):19513-8.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.48 , pp. 19513-19518
    • Saborowski, A.1    Saborowski, M.2    Davare, M.A.3    Druker, B.J.4    Klimstra, D.S.5    Lowe, S.W.6
  • 24
    • 80052055991 scopus 로고    scopus 로고
    • ROS receptor tyrosine kinase: a new potential target for anticancer drugs
    • El-Deeb IM, Yoo KH, Lee SH. ROS receptor tyrosine kinase: a new potential target for anticancer drugs. Med Res Rev. 2011;31(5):794-818.
    • (2011) Med Res Rev , vol.31 , Issue.5 , pp. 794-818
    • El-Deeb, I.M.1    Yoo, K.H.2    Lee, S.H.3
  • 27
    • 84904372791 scopus 로고    scopus 로고
    • ROS kinase fusions are not common in Chinese patients with cholangiocarcinoma
    • Liu P, Wu Y, Sun L, Zuo Q, Shi M. ROS kinase fusions are not common in Chinese patients with cholangiocarcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(4):474-8.
    • (2013) Nan Fang Yi Ke Da Xue Xue Bao , vol.33 , Issue.4 , pp. 474-478
    • Liu, P.1    Wu, Y.2    Sun, L.3    Zuo, Q.4    Shi, M.5
  • 29
    • 84870879515 scopus 로고    scopus 로고
    • Classification, diagnosis, and management of cholangiocarcinoma
    • Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11(1):13-21. e11; quiz e13-14.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , Issue.1 , pp. 13-21
    • Razumilava, N.1    Gores, G.J.2
  • 30
    • 84904384871 scopus 로고    scopus 로고
    • ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases
    • Warth A, Muley T, Dienemann H, Goeppert B, Stenzinger A, Schnabel PA, et al. ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases. Histopathology. 2014.
    • (2014) Histopathology
    • Warth, A.1    Muley, T.2    Dienemann, H.3    Goeppert, B.4    Stenzinger, A.5    Schnabel, P.A.6
  • 31
    • 84871784888 scopus 로고    scopus 로고
    • ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms
    • Lee HJ, Seol HS, Kim JY, Chun SM, Suh YA, Park YS, et al. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms. Ann Surg Oncol. 2013;20(1):200-8.
    • (2013) Ann Surg Oncol , vol.20 , Issue.1 , pp. 200-208
    • Lee, H.J.1    Seol, H.S.2    Kim, J.Y.3    Chun, S.M.4    Suh, Y.A.5    Park, Y.S.6    Kim, S.W.7    Choi, C.M.8    Park, S.I.9    Kim, D.K.10
  • 32
    • 84875877241 scopus 로고    scopus 로고
    • ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity
    • Eom M, Lkhagvadorj S, Oh SS, Han A, Park KH. ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity. Yonsei Med J. 2013;54(3):650-7.
    • (2013) Yonsei Med J , vol.54 , Issue.3 , pp. 650-657
    • Eom, M.1    Lkhagvadorj, S.2    Oh, S.S.3    Han, A.4    Park, K.H.5
  • 36
    • 84905016551 scopus 로고    scopus 로고
    • Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells
    • Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, et al. Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells. Int J Mol Med. 2014;34(3):661-8.
    • (2014) Int J Mol Med , vol.34 , Issue.3 , pp. 661-668
    • Deng, G.1    Hu, C.2    Zhu, L.3    Huang, F.4    Huang, W.5    Xu, H.6    Nie, W.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.